Pharmaceutical industry 4.0: Future, Challenges and Application

The pharmaceutical industry is on the cusp of a new age, with the need for personalized therapy, more complex production processes, smaller batch sizes and rising manufacturing costs. It is necessary to continuously adapt to the rapidly changing environment using novel technology and improved operational efficiency and flexibility. To achieve this, intelligent manufacturing seems to be a definite answer. Pharma 4.0 is a framework for adapting digital strategies to the unique contexts of pharmaceutical manufacturing. This book provides a deep insight into key technologies that will modernize pharmaceutical manufacturing and facilitate digital transformation. Throughout the book we discuss technologies, application and challenges for applying digital technology in pharmaceutical industry, including:

• Focus on an overview of Industry 4.0 and its application in the pharmaceutical field

• Most recent advances in the pharmaceutical industry

• Understanding the concepts of emerging technology trends for drug discovery.

Dr. Rishabha Malviya gained his B.Pharm. from Uttar Pradesh Technical University and M.Pharm. (Pharmaceutics) from Gautam Buddha Technical University, Lucknow Uttar Pradesh. His Ph.D. (Pharmacy) work was in the area of Novel formulation development techniques. He has 11 years of research experience and has worked as Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University for the past 8 years. His areas of interest include formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery and characterization of natural polymers as pharmaceutical excipients. He has authored more than 150 research/review papers for national/international journals of repute. He has 51 patents (12 grants, 38 published, 1 filed) and publications in reputed National and International journals with a total of 91 cumulative impact factor. He has also received an Outstanding Reviewer award from Elsevier. He has edited 11 books (Wiley, Springer Nature, CRC Press/Taylor and Francis, Apple Academic Press, River Publishers and OMICS Publishing Group) and authored 12 book chapters. His name was included in the World's top 2% scientist list for the year 2020 by Elsevier BV and Stanford University. He is a reviewer/editor/editorial board member for more than 50 national and international journals of repute. He has been invited as author for "Atlas of Science" and pharma magazine dealing with industry (B2B) "Ingredient South Asia Magazines".

Professor Sonali Sundram completed her B.Pharm. and M.Pharm. (pharmacology) from AKTU, Lucknow. She worked as a research scientist in a project of ICMR in King George's Medical University, Lucknow before joining BBDNIIT, and is currently working in Galgotias University, Greater Noida. Her Ph.D. (Pharmacy) work was in the area of neurodegeneration and nanoformulation. Her areas of interest are neurodegeneration, clinical research, and artificial intelligence. She has edited four books (Wiley, CRC Press/Taylor and Francis, River Publisher). She has attended, as well as organized, more than 15 national and international seminars/conferences/workshops. She has more than eight patents, national and international, to her credit.

Dr. Shivkanya Fuloria is presently working as an Associate Professor at Faculty of Pharmacy, AIMST University, Malaysia, with extensive experience of 18 years in research and academics. She completed her D.Pharm. in 1998 (Maharashtra, India), B.Pharm. in 2001 (Amravati University, India), M.Pharm. in 2003 (Nagpur University, India), and Ph.D. in 2011 (Amravati University, India). So far, she has supervised 7 Postgraduate and 20 undergraduate research scholars, and is currently supervising 5 Ph.D. scholars. She has published 89 research and review articles, 4 books, 3 MOOC, and 2 patents (Australia). For her research Dr. Shivkanya has received 7 national and international grants. Dr. Shivkanya is a member of various professional bodies like Indian Society of Analytical Scientists, IPGA, APTI, and NMR Society of India. Apart from her work in academics and research she has received various awards such as a Best Presentation Award 2017 (at 19th International Conference on Medicinal Chemistry and Molecular Pharmacology, Singapore), and an Appreciation Award 2017 (at Teachers Award Ceremony of Kedah State Malaysia, at AIMST University, Malaysia).

Dhanalekshmi Unnikrishnan Meenakshi holds a doctorate in Pharmacology (specialization in nanomedicine) from the Council of Scientific and Industrial Research (CSIR) - CLRI, India. She worked as a Scientist in the Council of Scientific and Industrial Research - NEIST, India, and was involved in the government-funded projects for the North East Exploration of Pharmaceuticals from natural sources. She has over 10 years of research and teaching experience with leading national and international organizations. She has worked on an array of projects relating to cancer and gene therapy, nanotechnology, and pharmacology. Her research areas are preclinical and clinical trials, mechanism of intoxication, etc. She uses state-of-the-art technology, for systematic evaluation of the efficiency of novel polymeric nanoparticles encapsulated with biologically active agents. Currently, she is a faculty member in the College of Pharmacy, National University of Science and Technology, Muscat, Sultanate of Oman. She has published extensively in nanomedicine, drug delivery, and formulation technology in peer-reviewed reputed journals and books. She has various awards and fellowships for her excellent contributions in her respective fields.